Search research articles
Contact Us
Filters
Showing results (541-550 of 716) with videos related to
Page
of 72
Sort By:
European Journal of Endocrinology
|
July 1, 2010
Abnormal cardiac contractility in long-term exogenous subclinical hyperthyroid patients as demonstrated by two-dimensional echocardiography speckle tracking imaging
Randa M Abdulrahman, Victoria Delgado, Arnold C T Ng, et al.
Circulation
|
February 18, 1997
Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis
E R Holman, V G Buller, A de Roos, et al.
The American Journal of Cardiology
|
February 24, 2009
Comparison of time course of response to cardiac resynchronization therapy in patients with ischemic versus nonischemic cardiomyopathy
Nina Ajmone Marsan, Gabe B Bleeker, Rutger J van Bommel, et al.
Heart (British Cardiac Society)
|
February 21, 2007
Tissue synchronisation imaging accurately measures left ventricular dyssynchrony and predicts response to cardiac resynchronisation therapy
Nico R Van de Veire, Gabe B Bleeker, Johan De Sutter, et al.
American Heart Journal
|
November 11, 2019
Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS
Neha J Pagidipati, Yinggan Zheng, Jennifer B Green, et al.
The Journal of Biological Chemistry
|
May 7, 2016
Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression
Victoria Stepanova, Padma-Sheela Jayaraman, Sergei V Zaitsev, et al.
Journal of Molecular and Cellular Cardiology
|
June 1, 2022
Standardised method for cardiomyocyte isolation and purification from individual murine neonatal, infant, and adult hearts
Amy M Nicks, Sara R Holman, Andrea Y Chan, et al.
Diabetes Care
|
February 13, 2008
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
, G R Dagenais, H C Gerstein, et al.
Diabetologia
|
November 11, 2006
Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76
R Calle, M I McCarthy, P Banerjee, et al.
European Journal of Heart Failure
|
August 30, 2011
The effect of cardiac resynchronization therapy on left ventricular diastolic function assessed with speckle-tracking echocardiography
Miriam Shanks, M Louisa Antoni, Ulas Hoke, et al.
Page
of 72
Search research articles
Search
Showing results (541-550 of 716) with videos related to
Sort By:
Page
of 72
European Journal of Endocrinology
|
July 1, 2010
Abnormal cardiac contractility in long-term exogenous subclinical hyperthyroid patients as demonstrated by two-dimensional echocardiography speckle tracking imaging
Randa M Abdulrahman, Victoria Delgado, Arnold C T Ng, et al.
Circulation
|
February 18, 1997
Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis
E R Holman, V G Buller, A de Roos, et al.
The American Journal of Cardiology
|
February 24, 2009
Comparison of time course of response to cardiac resynchronization therapy in patients with ischemic versus nonischemic cardiomyopathy
Nina Ajmone Marsan, Gabe B Bleeker, Rutger J van Bommel, et al.
Heart (British Cardiac Society)
|
February 21, 2007
Tissue synchronisation imaging accurately measures left ventricular dyssynchrony and predicts response to cardiac resynchronisation therapy
Nico R Van de Veire, Gabe B Bleeker, Johan De Sutter, et al.
American Heart Journal
|
November 11, 2019
Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS
Neha J Pagidipati, Yinggan Zheng, Jennifer B Green, et al.
The Journal of Biological Chemistry
|
May 7, 2016
Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression
Victoria Stepanova, Padma-Sheela Jayaraman, Sergei V Zaitsev, et al.
Journal of Molecular and Cellular Cardiology
|
June 1, 2022
Standardised method for cardiomyocyte isolation and purification from individual murine neonatal, infant, and adult hearts
Amy M Nicks, Sara R Holman, Andrea Y Chan, et al.
Diabetes Care
|
February 13, 2008
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
, G R Dagenais, H C Gerstein, et al.
Diabetologia
|
November 11, 2006
Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76
R Calle, M I McCarthy, P Banerjee, et al.
European Journal of Heart Failure
|
August 30, 2011
The effect of cardiac resynchronization therapy on left ventricular diastolic function assessed with speckle-tracking echocardiography
Miriam Shanks, M Louisa Antoni, Ulas Hoke, et al.
Page
of 72